All Episodes
WCG Talks Trials — 89 episodes
Breaking the Bottleneck: Rethinking Study Start-Up for Faster Trial Activation
Complexity to Catalyst: Building Site Readiness, Resilience & Innovation
AI & Digital Health: Advancing Access & Innovation in Latin American Trials
Health Literacy in Action: The Impact of Plain Language Communication in Clinical Research
Advancing Access: How SaaS is Transforming Clinical Trials
Advancing Imaging in Clinical Trials Using AI
Future-Ready Research: Optimizing Sites for Continued Success
Harnessing Generative AI in Clinical Research
AI in Clinical Trials: Unlocking the Potential
Breaking Down Site Complexities and Start-Up Barriers in Clinical Trials
From Patient Care to Discovery: A Clinician's Journey into Research
Inside MAGI: Innovation, Education, and Industry Trends
Revolutionizing Clinical Research Through Collaboration and Innovation
Have a Safe Trip: Clinical and Patient Alignment in Research with Psychedelics
Breaking Barriers: Reasons to Expand Site Cancer Trial Portfolios
Patient Advocacy Advancing Breakthrough Science and Community Engagement
Guarding Research Integrity: The IRB's Essential Role
Addressing Challenges in Site Feasibility
Ethical Review and AI in Clinical Trials
Addressing Measurement Challenges for PTSD Trials with Technology
What Is E-Consent? Interview with Erin Brower
Creating Partnerships: Aligning Vendor Support for Success in Clinical Research
WCG's IRB Policy Change: Harmonizing Consent (Part 2)
WCG's IRB Policy Change: Harmonizing Consent (Part 1)
The Ethical and Safety Considerations of Accelerating Oncology Trials
Embarking on a Research Revolution – A Conversation with Florence Healthcare
The CRA’s Evolving Role in a Postpandemic Industry
MAGI@home: Practical Intelligence, Real-life Examples, Actionable Information
Diversity & Inclusion with Technology in Decentralized Trials
Amplifying Patient Voices to Advance Clinical Research: The Importance of Patient Advocacy
The Importance of Diversity, Equity, Inclusion, and Intersectionality in Clinical Research
Delve into the World of Psychedelic Research and Ethical Inquiry
A 360-degree View on Motivators and Deterrents to Clinical Trial Participation
Breaking Down Enrollment Barriers: How DE&I, Technology, and Protocol Design Impact Enrollment Success
Unlocking Site Potential: Reducing Site Burden and Enhancing Clinical Trial Efficiency
Connecting Patients to Trials: Bernadette Siddiqi of The Michael J. Fox Foundation for Parkinson’s Research
On the Future of Movement Disorder Trials: Part 4 of WCG’s Transforming CNS Trials Series
Prostate Cancer Survivor Bryce Olson’s Message: “Sequence Me!”
On the Future of Depression Trials: Part 3 of WCG’s Transforming CNS Trials Series
LaTasha H. Lee, PhD, MPH: Advocating for Health Equity, Advancing Sickle Cell Disease Research
Jeffrey Borghoff: Finding Joy and Purpose after an Early-Onset Alzheimer’s Diagnosis
On the Future of Schizophrenia Trials: Part 2 of WCG’s Transforming CNS Trials Series
Lisa Deck: Young Stroke Survivor Transforms Life-Altering Challenge into Purpose-Driven Advocacy for Others
The Case for Centralized Monitoring: Optimizing Data Quality and Risk Management with Linda Sullivan and Steve Young
Michael Poku, MD, MBA: Improving Minority Representation in Clinical Trials
Dana Deighton: Esophageal Cancer Patient and Persistent Activist For Her Own Survival
Striving for Reliability: Optimizing Patient Report Data through World-Class Design Management with Linda Sullivan, Nat Katz, and Art Morales
The Upside of Centralized Monitoring During a Pandemic: Linda Sullivan, Duncan Hall, and Rachel Oakley on Optimizing Clinical Trials through Innovative RBQM Technology
Get Rid of Those Silos: Linda Sullivan, Artem Andrianov, and Johann Proeve on How To Optimize Clinical Trials through RBQM
Gregory L. Hall, MD: Writing the Book on Health Disparities in African Americans
Turning Insights Into Action: Linda Sullivan and Ken Getz on How Metrics and Benchmarking Provide a Path To Optimizing Clinical Trials
Peter A. DiBiaso, MHA: Taking on the Ironman, Mount Kilimanjaro and Parkinson’s disease: a clinical trials patient recruitment expert speaks about his own life as a patient
Lisa Carlton, PhD: Fighting Rare Diseases as a Mother, Patient Advocate and Regulatory Affairs Professional
Now Is the Time: Making Your Clinical Trial More Resilient
Hong Liu, PhD, Making Chicago a Healthier City for Asian Americans
Roslyn Daniels, Black Health Matters Founder and President, on Health Disparities and Exciting Communities About Health
Dorelia Rivera: Health Disparities, a Career in Advocacy, and Saving Her Daughter’s Life
Christopher Gantz, Building Trust and minority enrollment in clinical trials at Thomas Jefferson Hospital in Philadelphia
Communicating the Value of Clinical Trials to Underserved Minority Communities
People, Process and Technology: The Right Combination for Successful Expert Committees
Bringing Clinical Trials Closer to Home: Smaller, Local Sites Build Trust & Provide Access to Local Communities
Raise Your Voices: Social Network Provides Safe Place for Patients to Share Stories and Influence Research
Brian Loew, The INSPIRE social network platform provides a safe place for patients to meet, learn, and influence research
Frank Sasinowski, MS, MPH, JD Hymen Phelps & McNamara: Rare Disease Regulatory Transformation: 1983 AIDS Crisis to Present
Thomas Farrington: Cancer Survivor’s Prostate Health Network gets African American Communities Talking About Prostate Cancer
We Should Not Be Surprised: COVID-19 Disparities Lay Bare What’s Been There All Along
COVID-19 Doesn’t Play Fair: What We Need to Understand About Racial Disparities
Dr. David Fajgenbaum, MD, Castleman’s Disease Survivor, Facing COVID-19 with Research, Action, and Hope
Turning Passion Into a Career: Insights from a Physician and Industry Medical Director of AbbVie Pharmaceuticals, Charlotte Owens, MD, FACOG
Biostatistics and Biomarkers for the Reliability and Efficiency of Clinical Trials: A Conversation with Dr. Janet Wittes
An Inside Look at the Role of Data Monitoring Committees with Dr. Jonathan Seltzer
An Interview with Dr. Jeffrey Cooper: Clinical Trial Expert and Participant
Julia Jenkins, EveryLife Foundation for Rare Diseases: Patient’s shape science-driven public policy
Ensuring Genetic Counseling is Incorporated Into the Patient Experience: An Interview with Sarah Zentack & Leslie Urdaneta
The Role and Importance of Genetic Counselors to Patients: An Interview with Karmen Trzupek of InformedDNA
Sarah Tompkins, on Having Ehlers-Danlos Syndrome, Having a Mis-Understood Disease, and Taking a Lead in Advocacy
Blazing New Trails in Rare Disease & CNS Clinical Studies: An Interview with Dr. Mark Opler
An Inside Look at Angelman Syndrome Rare Disease: An Interview with Amanda Moore
Learning How to See Differently: An Interview with Kristin Smedley, President of the Curing Retinal Blindness Foundation
Developing Novel Treatments for Rare Disorders: A Look at MPS I with Dr. Emil Kakkis
Mark Dant, Pushing for Research that Saved His Son’s Life in the Fight Against MPS I
Chasing My Cure: an Interview with Dr. Fajgenbaum
The State of Clinical Trials in Autism and Neurodevelopmental Disorders with Dr. Scott Hunter
The New Paradigm of Patient Recruitment: an interview with Mark Summers
Exciting Developments in Psychopharmacology with guest Andrew Cutler, MD
The Role of Expert Committees in Clinical Research with guest Jonathan Seltzer, MD, MBA, MA, FACC
The Most Pressing Challenges and Opportunities in Pain Research with guest Nathaniel Katz, MD, MS
Important Trends in CNS Clinical Trials with guest Cristoph Correll, MD
The Most Pressing Challenges in Psychiatry Clinical Trials with Leslie Citrome, MD, MPH